Discover
PYXS
Pyxis Oncology, Inc.
2.85
2 x 2.24
2 x 3.63
bid
ask
-
0.16
5.32%
2 @ 04:00 PM
2.90 +0.05 (1.75%)
| Ytd | 147.83% | |
| 1y | 137.50% |
2.83
day range
3.19
0.97
52 week range
5.55
| Open | 3.01 | Prev Close | 3.01 | Low | 2.83 | High | 3.19 | Mkt Cap | 180.56M |
| Vol | 773.19K | Avg Vol | 761.51K | EPS | -1.30 | P/E | N/A | Forward P/E | -1.40 |
| Beta | 1.28 | Short Ratio | 3.13 | Inst. Own | 56.55% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 2.01 | 200-d Avg | 2.32 | 1yr Est | 10.00 |
PYXS News
benzinga.com
Pyxis Oncology Commences ~$50M Offering Of 19.6M Common Shares At $2.551/Share
Pyxis Oncology, Inc. (NASDAQ:PYXS), a clinical-stage company developing next-generation therapeutics
globenewswire.com
Pyxis Oncology Announces Up to $114 Million Private Placement Financing to Advance MICVO Through Key
Expected to extend cash runway into the second quarter of 2027, supporting additional follow-up for
benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers INVO Fertility (NASDAQ:IVF) shares moved upwards by 67.3% to $2.08 during Friday's regu